Biomarker threshold adaptive designs for survival endpoints. [electronic resource]
Producer: 20191025Description: 1038-1054 p. digitalISSN:- 1520-5711
- Algorithms
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Agents, Immunological -- therapeutic use
- Biomarkers, Tumor -- genetics
- Biostatistics -- methods
- Clinical Decision-Making
- Clinical Trials, Phase III as Topic -- methods
- Computer Simulation
- Data Interpretation, Statistical
- ErbB Receptors -- antagonists & inhibitors
- Head and Neck Neoplasms -- drug therapy
- Humans
- Models, Statistical
- Neoplasms -- drug therapy
- PTEN Phosphohydrolase -- genetics
- Panitumumab -- therapeutic use
- Patient Selection
- Precision Medicine -- methods
- Predictive Value of Tests
- Randomized Controlled Trials as Topic -- methods
- Research Design -- statistics & numerical data
- Squamous Cell Carcinoma of Head and Neck -- drug therapy
- Survival Analysis
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.